PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30077642-0	2018	Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment.	purvalanol B	16-26	aldo-keto reductase family 1 member C3	Homo sapiens	102-125	
30077642-0	2018	Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment.	purvalanol B	16-26	aldo-keto reductase family 1 member C3	Homo sapiens	127-133